The authors of Gutierrez JE, Rosenberg M, Seemann J, et al. Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study. Magnetic Resonance Insights. 2015;8:1-10. doi:10.4137/MRI.S19794 wish to advise that there was an error in the text on page 6 of the paper, in the sentences describing Figure 5 . This text should have read as follows: Figure 5 shows a patient with brain metastasis from lung cancer. The gadobutrol-enhanced T1w image (a) shows a small foci of increased signal intensity near the gray-white interphase in the left temporal lobe, which was interpreted as a metastatic tumor/carcinomatosis by the blinded readers (all three readers) (Fig. 5A) , whereas the gadoteridol-enhanced T1w image (b) had no identifiable foci and only a vague increase in signal intensity on this image and no increased signal intensity on the adjoining slices so the blinded readers did not diagnose a metastatic tumor nor carcinomatosis in the left temporal lobe (zero of three readers) when viewing the combined contrast-enhanced and pre-contrast images (Fig. 5B) .
The editor in chief thanks the authors for drawing their error to readers' attention.
